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Dear Editor,
We report a case of aggressive natural killer (NK) cell leu-
kaemia characterised by hepatitis C virus (HCV) and
Epstein–Barr virus (EBV) infection and multiple karyotype
abnormalities in a patient previously treated with radio-
chemotherapy for non-haematological cancer.
NK cell malignancies are rare haematopoietic tumours
usually associated with EBV infection [1, 2], and aggres-
sive NK cell leukaemia is an even rarer disease with a grim
prognosis [3–5]. It typically shows multi-organ involve-
ment leading to multi-organ failure and has an aggressive
course that responds poorly to chemotherapy [6, 7].
A 76-year-old white woman came to our hospital in
April 2003 complaining of fatigue, dyspnea and fever. Her
medical history included HCV-related liver cirrhosis and
ovarian cancer, which had been diagnosed 2 years earlier
and treated by means of surgery and radio-chemotherapy
with alkylating agents and topoisomerase II inhibitors.
Physical examination revealed multiple superficial lymph-
adenomegalies and liver and spleen enlargement. Labora-
tory examinations showed hyperleucocytosis (WBC 162×
109/l), mild thrombocytopenia (PLT 89×109/l) and high
LDH levels (1,486 U/l). Clotting tests showed increased
XDP (8,900 mg/dl) and a prolonged prothrombin time
(ratio 1.63). A peripheral blood smear revealed large un-
differentiated blasts with abundant and slightly granular
cytoplasm. A three-colour immunofluorescence assay of
peripheral blood (FACScalibur, Becton Dickinson, Boston,
MA, USA) showed the expression of CD1a, CD2, CD4,
CD16, CD43, CD30, CD56, CD11c and CD38, but there
was no detectable presence of CD33, CD13, CD19 or
surface or cytoplasmic CD3. She had a hypertriploid kar-
yotype with trisomy of all chromosomes and tetrasomy of
chromosomes 2, 10, 12 and 16. Furthermore, some struc-
tural abnormalities were also detected, including the long
arm deletion of chromosome 6 and an additional long arm
of chromosome 17.
PCR analysis revealed a germ line configuration of T-
cell receptor genes and identified EBV genome in the
leukaemic cells.
A diagnosis of aggressive NK cell leukaemia was made
and, given the patient’s poor performance status, she was
prescribed non-intensive treatment with cyclophosphamide
(500 mg/day i.v. for 3 days), vincristine (2 mg i.v) and 6-
methyl-prednisolone (60 mg/day i.v. for 3 days), which
partially reduced the hyperleucocytosis (WBC 240→74×
109/l).
However, the disease pursued a fulminant course: dis-
seminated intravascular coagulation and multi-organ fail-
ure ensued, and the patient died 30 days after being
diagnosed.
Autopsy revealed adult respiratory distress syndrome
and NK cell infiltration of the bone marrow, spleen, liver,
lymph nodes, lungs and heart by medium- to large-sized
haematopoietic blasts (Fig. 1). No skin involvement was
detected.
NK cell tumours constitute a group of highly heteroge-
neous lymphoproliferative disorders that have an aggres-
sive course and typical extra-nodal involvement. In our
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case, the NK cell origin was demonstrated by the ex-
pression of CD16 and CD56, the lack of CD3 expression
and a germ line T-cell receptor configuration.
The absence of skin involvement and the aberrant CD4
expression are unusual findings in NK cell leukaemia, but
the main peculiarity of this case is the association of
previous intensive chemotherapy and HCV-related cirrho-
sis. No case of chemotherapy-related NK disorders has so
far been described, whereas the association between acute
leukaemias and radio-chemotherapy is well-known [8].
Karyotype abnormalities have been reported in aggres-
sive NK leukaemia [9], although there are no published
descriptions of such an aberrant cytogenetic pattern. Some
of these abnormalities may represent non-random markers
of NK tumours, but it is not known whether specific genes
regulating NK development are located in these chromo-
somes. This karyotype may in fact have been the expres-
sion of multiple genotoxic factors: radio-chemotherapy and
HCV and EBV infection. Chronic HCV and EBV stimu-
lation of the immune system may have induced NK oli-
goclonal proliferation and allowed a further neoplastic
evolution. The role of HCV infection in the pathogenesis of
NK tumours is unknown: it may induce an increase in liver
NK cells [10, 11], but their function seems to be inhibited
[12]. EBV infection stimulates NK cell proliferation,
especially through IFN-γ production by EBV-infected T
lymphocytes [2].
In conclusion, this may have been a case of secondary
NK cell leukaemia, whose prognosis was made even worse
as a result of the associated HCV-related liver cirrhosis and
previous radio-chemotherapy for ovarian cancer and which
contributed to the multiple cytogenetic abnormalities.
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